68
Lukas Biomedical Inc.
6814.TWO · TWO
$17.40 +0.00% (+$0.00)
1M -27.50%
Market Cap $755.8M
P/E Ratio -
Div. Yield -
ROE 32.92%
Piotroski F-Score Weak
2/9Valuation
53 /100
Fair P/B 3.15x
P/S 4.21x
EV/EBITDA N/A
Growth
12 /100
Declining Book val. growth 9.82%
Rev. growth 0.96%
FCF growth N/A
Profitability
20 /100
Weak Net margin 47.71%
Op. margin 45.22%
FCF margin 38.97%
Quality
5 /100
Poor ROE 32.92%
ROA 20.06%
Asset turnover 0.42x
Debt
39 /100
Moderate Current ratio 0.80x
Int. coverage -25.28x
Debt/Equity 0.65x
Stability
25 /100
Unstable Rev. volatility 22.42%
EPS volatility 55.42%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6814.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chaoan Liu
Employees
87
Headquarters
New Taipei